EUVIMEDEUVIMED entdecken
Open Access

circSLCO1B7 suppresses the malignant progression of hepatocellular carcinoma via the miR-556-3p/DAB2IP axis

Linling Ju, Qian Zhou, Qianyi Qi, Yongjun She, Weihua Cai, Yali Cao, Rujian Lu, Jianguo Shao, Lin Chen

Aging · 2023

DOI: 10.18632/aging.205244 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Linling Ju und 8 weiteren Autor:innen. Beteiligte Einrichtung: Medical School of Nantong University, Nantong University, Affiliated Nantong Hospital 3 of Nantong University, Nantong Third People`s Hospital, Nanto…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, MicroRNAs. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsMicroRNAsHumansCell Line, TumorCell MovementCell ProliferationEpithelial-Mesenchymal TransitionGene Expression Regulation, Neoplasticras GTPase-Activating ProteinsRNA, CircularOrganic Anion TransportersSolute Carrier Proteins

Stichwörter der Autor:innen

DAB2IPEMTcircSLCO1B7hepatocellular carcinomamiR-556-3p

Substanzen

MicroRNAsras GTPase-Activating ProteinsRNA, CircularDAB2IP protein, humanMIRN556 microRNA, humanSLCO1B7 protein, humanOrganic Anion TransportersSolute Carrier Proteins

Autor:innen und Institutionen

  • Medical School of Nantong University, Nantong University, Affiliated Nantong Hospital 3 of Nantong University, Nantong Third People`s Hospital, Nantong 226000, Jiangsu, China.
  • Department of Gastroenterology, Changshu Second People’s Hospital, Changshu 215500, Jiangsu, China.
  • Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong 226001, Jiangsu, China.

Zitieren

APA

Ju, L., Zhou, Q., Qi, Q., She, Y., Cai, W., Cao, Y., Lu, R., Shao, J., & Chen, L. (2023). circSLCO1B7 suppresses the malignant progression of hepatocellular carcinoma via the miR-556-3p/DAB2IP axis. Aging. https://doi.org/10.18632/aging.205244

Vancouver

Ju L, Zhou Q, Qi Q, She Y, Cai W, Cao Y, et al. circSLCO1B7 suppresses the malignant progression of hepatocellular carcinoma via the miR-556-3p/DAB2IP axis. Aging. 2023. doi:10.18632/aging.205244

BibTeX
@article{Ju2023,
  author = {Ju, Linling and Zhou, Qian and Qi, Qianyi and She, Yongjun and Cai, Weihua and Cao, Yali and Lu, Rujian and Shao, Jianguo and Chen, Lin},
  title = {circSLCO1B7 suppresses the malignant progression of hepatocellular carcinoma via the miR-556-3p/DAB2IP axis},
  journal = {Aging},
  year = {2023},
  doi = {10.18632/aging.205244}
}
Kostenlos starten →